No abstract available
Keywords:
anti-vascular endothelial growth factor; chronic myeloid; leukaemia; leukostasis retinopathy; macular oedema.
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetic Retinopathy / diagnosis*
-
Humans
-
Incidental Findings
-
Intravitreal Injections
-
Laser Coagulation
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Macular Edema / diagnosis
-
Macular Edema / drug therapy
-
Male
-
Middle Aged
-
Receptors, Vascular Endothelial Growth Factor / therapeutic use
-
Recombinant Fusion Proteins / therapeutic use
-
Retinal Neoplasms / diagnosis*
-
Retinal Neoplasms / drug therapy
-
Retinal Neovascularization / diagnosis
-
Retinal Neovascularization / drug therapy
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vision, Low / diagnosis*
-
Visual Acuity / physiology
Substances
-
Angiogenesis Inhibitors
-
Recombinant Fusion Proteins
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
aflibercept
-
Receptors, Vascular Endothelial Growth Factor